iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionFounders Capital Management
Latest Disclosed Ownership6 shares
Latest Disclosed Value $ 1,032
Founders Capital Management ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 21, 2026 - Founders Capital Management filed a 13F-HR form disclosing ownership of 6 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,032 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 6 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $786 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.00 0.0005
2026-01-15 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2025-07-18 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2025-04-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2025-01-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2024-10-07 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2024-07-10 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0005
2024-04-10 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0006
2024-01-08 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 0 0.00 1 0.0006
2023-10-10 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6 -300 -98.04 1 -100.00 0.0006
2023-07-07 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 306 0 0.00 39 0.0283
2023-04-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 306 -17,483 -98.28 0 -100.00 0.0306
2023-01-09 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 17,789 0 0.00 2 -99.90 1.7554
2022-10-06 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,789 -2,811 -13.65 2,081 -14.11 1.6982
2022-07-20 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,600 -2,205 -9.67 2,423 -30.39 1.9098
2022-04-07 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 22,805 0 0.00 3,481 0.00 2.2316
2022-01-21 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 22,805 -116 -0.51 3,481 -6.07 2.2316
2021-10-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 22,921 -1,194 -4.95 3,706 -6.08 2.5405
2021-07-15 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 24,115 -290 -1.19 3,946 7.40 2.5721
2021-06-09 2021-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 24,405 1,535 6.71 3,674 6.03 2.6150
2021-06-07 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 24,405 1,535 6 0.0658
2021-01-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 22,870 18,850 468.91 3,465 700.23 2.4503
2020-04-22 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,020 0 0.00 433 -10.54 0.4491
2020-01-24 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,020 749 22.90 484 48.92 0.3663
2019-10-10 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,271 380 13.14 325 3.17 0.2600
2019-07-11 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,891 480 19.91 315 16.67 0.2778
2019-04-17 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,411 40 1.69 270 17.90 0.2531
2019-01-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,371 80 3.49 229 -17.92 0.2444
2018-10-05 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,291 1,625 243.99 279 282.19 0.2301
2018-07-09 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 666 -774 -53.75 73 -52.60 0.0641
2018-04-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,440 0 0.00 154 0.00 0.1297
2018-01-22 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,440 960 200.00 154 -3.75 0.1277
2017-10-17 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 480 -30 -5.88 160 1.27 0.1326
2017-07-19 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 510 0 0.00 158 5.33 0.1400
2017-05-09 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 510 510 150 0.1348
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.